Getting Through Leukemia Together: Karen's Immunotherapy Story
When Karen Koehler's chronic lymphocytic leukemia (CLL) transitioned into high gear, she knew she wanted to look beyond the standard treatment options. #PatientStories #CIM16
That brought her to a clinical trial of CAR T cell therapy, a new type of immunotherapy that re-engineers immune cells and teaches them to fight cancer. A year after the treatment, Karen remains cancer-free. www.cancerresearch.org/patients.
This video is presented as part of the Cancer Research Institute 4th Annual Cancer Immunotherapy Month awareness campaign this June 2016. Help us raise awareness of the lifesaving potential of immunotherapy for all types of cancer. Let's fuel the next scientific discoveries and breakthrough treatments through learning, engagement, and storytelling. http://www.cancerresearch.org/june
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune systemโs power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the fieldโs leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org
No comments found